ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,168 | +4.9% | 204,700 | -0.0% | 0.03% | +21.7% |
| Q2 2023 | $18,270 | -31.4% | 204,703 | -17.6% | 0.02% | -36.1% |
| Q1 2023 | $26,646 | -14.6% | 248,521 | -2.7% | 0.04% | -16.3% |
| Q4 2022 | $31,205 | -99.9% | 255,506 | -8.1% | 0.04% | +2.4% |
| Q3 2022 | $28,718,000 | +13.1% | 278,117 | +1.8% | 0.04% | +27.3% |
| Q2 2022 | $25,396,000 | -27.1% | 273,198 | -8.0% | 0.03% | -10.8% |
| Q1 2022 | $34,835,000 | -9.6% | 296,823 | +3.6% | 0.04% | -5.1% |
| Q4 2021 | $38,547,000 | -27.4% | 286,532 | -14.0% | 0.04% | -31.6% |
| Q3 2021 | $53,097,000 | +41.8% | 333,129 | +17.0% | 0.06% | +46.2% |
| Q2 2021 | $37,448,000 | +5.1% | 284,668 | +3.0% | 0.04% | 0.0% |
| Q1 2021 | $35,619,000 | -21.1% | 276,377 | +2.0% | 0.04% | -22.0% |
| Q4 2020 | $45,171,000 | +1.8% | 270,842 | -5.8% | 0.05% | -7.4% |
| Q3 2020 | $44,393,000 | +18.1% | 287,666 | +13.2% | 0.05% | +12.5% |
| Q2 2020 | $37,590,000 | +22.3% | 254,155 | -6.9% | 0.05% | +4.3% |
| Q1 2020 | $30,741,000 | -14.0% | 272,984 | +6.2% | 0.05% | +7.0% |
| Q4 2019 | $35,765,000 | +40.5% | 257,083 | -2.7% | 0.04% | +34.4% |
| Q3 2019 | $25,456,000 | -17.1% | 264,283 | -0.9% | 0.03% | -15.8% |
| Q2 2019 | $30,705,000 | +11.9% | 266,648 | +14.4% | 0.04% | +8.6% |
| Q1 2019 | $27,430,000 | +87.9% | 233,048 | -0.0% | 0.04% | +66.7% |
| Q4 2018 | $14,601,000 | +27.7% | 233,049 | +44.4% | 0.02% | +50.0% |
| Q3 2018 | $11,436,000 | +42.5% | 161,393 | +33.7% | 0.01% | +40.0% |
| Q2 2018 | $8,028,000 | +19.4% | 120,691 | +17.4% | 0.01% | +25.0% |
| Q1 2018 | $6,726,000 | – | 102,839 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |